SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000906709-21-000014
Filing Date
2021-08-06
Accepted
2021-08-05 21:47:31
Documents
60
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nktr-20210630.htm   iXBRL 10-Q 1501854
2 EX-10.1 nktr2021-06x30xexx101.htm EX-10.1 142591
3 EX-31.1 nktr2021-06x30xexx311.htm EX-31.1 9510
4 EX-31.2 nktr2021-06x30xexx312.htm EX-31.2 9524
5 EX-32.1 nktr2021-06x30xexx321.htm EX-32.1 6027
  Complete submission text file 0000906709-21-000014.txt   6029253

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nktr-20210630.xsd EX-101.SCH 46623
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nktr-20210630_cal.xml EX-101.CAL 61308
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nktr-20210630_def.xml EX-101.DEF 174935
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nktr-20210630_lab.xml EX-101.LAB 482846
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nktr-20210630_pre.xml EX-101.PRE 297439
11 EXTRACTED XBRL INSTANCE DOCUMENT nktr-20210630_htm.xml XML 913756
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 211150384
SIC: 2834 Pharmaceutical Preparations